Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 304 followers
Latest posts
Last updated about 16 hours ago
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
about 16 hours ago
Susvimo is the first and only continuous delivery treatment that offers an...
Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU
5 days ago
As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor...
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2024 results with 7% sales growth; fourth quarter marks third straight quarter of 9% growth
6 days ago
Basel, 30 January 2025 Group sales grew by 7%1 at constant exchange...
Change to the Roche Enlarged Corporate Executive Committee
7 days ago
Basel, 29 January 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
Roche’s Itovebi demonstrated statistically significant and clinically meaningful overall survival benefit in a certain type of HR-positive advanced breast cancer
8 days ago
Updated overall survival (OS) results - a key secondary endpoint - reinforce...
Roche announces new results from EMBARK demonstrating significant sustained benefits of Elevidys in ambulatory individuals with Duchenne muscular dystrophy (DMD)
9 days ago
Across three key functional outcomes, North Star Ambulatory Assessment (NSAA), Time to...
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
14 days ago
More than 1 million curable sexually transmitted infections (STIs) are acquired every...
Roche purchases shares in tender offer for Poseida Therapeutics, Inc.
28 days ago
Basel, 8 January 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease
about 2 months ago
PADOVA study showed numerical delay in motor progression and positive trends on...
Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution
about 2 months ago
Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the...
Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness
about 2 months ago
Vabysmo PFS is the first and only prefilled syringe containing a bispecific...
Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities
about 2 months ago
The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample...